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Abstract
Background: Four decades of population-based tobacco control strategies have contributed to substantial
reduction in smoking prevalence in Australia. However, smoking prevalence is still double in socially disadvantaged
groups compared to those that are not. But not all tobacco control strategies successfully used in the general
population is effective in specific high-risk population groups. Hence, an effective way to reduce smoking in high
risk population groups may include targeting them specifically to identify and support smokers to quit. In this
backdrop, we examined whether tobacco control interventions at the population-level are more effective in
increasing life expectancy among Australians compared to interventions targeting a high risk group or a
combination of the two when smoking prevalence is reduced to 10 and 0% respectively.
Methods: Using the risk percentiles approach, analyses were performed separately for men and women using data
from various sources such as the 2014–15 National Health Survey linked to death registry, simulated data for high
risk groups, and the Australian population and deaths data from the census. Indigenous status was simulated by
preferentially assigning those who are indigenous to lower SES quintiles. The age-sex distribution of mental
disorder status was simulated using its distribution from 2016 National Drug Strategy Household Survey with 25.9%
of mentally ill being assigned to current smoking category and the rest to non-smoking category. The age-sex
distribution of prisoners was simulated based on 2014 ABS Prisoners Australia survey with 74% of prisoners being
assigned to current smoker category and the rest to non-smoker category. Homelessness status was simulated
according to age, sex and indigenous status for 2011 census with all homeless being allocated to the lowest SES
category. The age-sex distribution of total cholesterol level was simulated based on 2011–13 Australian Health
Survey.
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Results: The results showed that the combined approach for reducing smoking is most effective for improving life
expectancy of Australians particularly for the socially disadvantaged and mentally ill groups both of which have
high fraction of smokers in the population. For those who were mentally ill the gain in ALE due to reduction of
smoking to 10% was 0.53 years for males and 0.36 years for females which were around 51 and 42% respectively of
the maximal gains in ALE that could be achieved through complete cessation.
Conclusions: Targeting high-risk population groups having substantial fraction of smokers in the population can
strongly complement the existing population-based smoking reduction strategies. As population and high risk
approaches are both important, the national prevention policies should make judicious use of both to maximize
health gain.
Keywords: Smoking reduction, Population approach, High risk approach, Combined approach, Average life
expectancy, Risk percentiles method
Background
Tobacco smoking is a key risk factor of the four diseases,
namely, coronary heart disease, lung cancer, stroke and
coronary obstructive pulmonary disease (COPD) that
cause most deaths in Australia. It is the single most im-
portant preventable cause of ill health and death accord-
ing to the Australian Burden of Disease study [1],
despite the fact that its prevalence in the Australian
population has been declining since the 1950s, and
Australia currently has one of the lowest rates of smok-
ing in the developed world, with a prevalence of current
daily smokers of 14.5% reported in 2014–15 among
adults aged 18 years and above [2]. Among risk factors,
smoking caused the most burden of disease in 2015 with
an estimated 77.7% of lung cancer, 72.4% of COPD and
40.3% of cardiovascular disease (CVD) burdens being at-
tributable to smoking [1]. For prior to age 65 and all
ages 38 and 16% of CVD deaths are attributable to
smoking [3]. Moreover, smoking contributes to more
drug-related hospitalisations and deaths than alcohol
and illicit drug use combined [4]. It is therefore a major
contributor to the costs of the health system. In addition
to the direct costs associated with provision of care for
smoking-related illness, additional costs to the commu-
nity include loss of productivity due to absenteeism and
reduction in the workforce resulting from premature
death.
Australia’s declining smoking prevalence is largely due
to the collective effects of the numerous population-
based tobacco control strategies introduced over the past
four decades. Smoking has declined in all socioeconomic
groups over time with the relative gap in smoking preva-
lence between the most and least disadvantaged groups
narrowing between 2013 and 2018 [5–8]. which is be-
cause smoking has declined more rapidly among disad-
vantaged smokers [7, 8]. However, smoking rates are
still double in least advantaged groups compared to the
most advantaged groups [6]. Because of this, one of the
key priority areas of Australia’s 2012–18 National
Tobacco Strategy is strengthening efforts to reduce
smoking among groups with a high prevalence of smok-
ing [9]. However, tobacco control measures effectively
used in the general population may not always be effect-
ive in specific high-risk populations, eg., a meta-analysis
of smoking cessation programs in highly disadvantaged
groups cited the lack of high-quality evidence among the
homeless, indigenous and prisoners [10, 11]. Therefore,
apart from population-based strategies, another way for
reducing smoking in high risk population groups may be
to specifically target these groups to more effectively
identify and support those smoking to quit (a.k.a high
risk approach).
It is unknown whether the population or high risk ap-
proach or a combination of the two, for reducing smok-
ing is more effective in prolonging life expectancy in the
Australian population. Accordingly, the aim of this paper
is to compare the relative effectiveness of these three
basic approaches for reducing smoking in a population.
For our analysis the smoking prevalence is reduced to 0
and 10% from its existing level, as various Australian
government institutions have come to a consensus in
their aim to reduce the national smoking prevalence to
10% by 2020 [12]. All analyses in this study are per-
formed separately for men and women. The high risk
population subgroups examined are socioeconomically
disadvantaged, prisoners, indigenous, homeless and
mentally ill, as these are among the major population
subgroups having high smoking prevalence [13]. Drug
use is not considered as a high risk group because smok-
ing prevalence was only around 16% among drug users
in 2010 [14]. while remoteness is not considered because
rural and remote regions of Australia are already more
likely to be of lower socioeconomic status [15].
Impact of key population-based smoking reduction
strategies on population subgroups of varying risks
The major population based approaches in context of
Australia include increase of tobacco taxes, bans on
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advertising, public health campaigns, smoke free legisla-
tion, jurisdictional bans and limitations on point-of-sale
display, mandatory graphic health warnings on pack-
aging and the introduction of plain packaging. For al-
most two decades tobacco excise was indexed to
inflation, until 2010, when there was a one-off increase
in excise to 25% with four subsequent annual increases
of 12.5% from 2013 to 2016. That has seen cigarette
prices increase from about 15 dollars a pack in 2010, to
around 25–30 dollars in 2016.
It has been noted that an important consideration in
the development of public health policy in Australia is
whether tobacco control strategies are as effective in
reaching high risk groups (e.g., low SES) as they are in
reducing smoking among normal or low risk groups
(e.g., high SES) [16–19]. During a period of strong to-
bacco control activity from 1997 till 2005 in Australia
[8], and from 1997 till 2011 in Victoria [7], smoking de-
clined across all population subgroups but it was fastest
in high risk groups (eg., low SES groups) among teen-
agers aged 12–15 years and adults respectively. Specific-
ally, for a large number of population-based tobacco
control strategies like the 2010 tax increase on tobacco
products [20, 21], higher merchant compliance with reg-
ulations on the supply of tobacco products [22], intro-
duction to smoke-free hospitality venues [23] and anti-
smoking mass media campaigns [23], smoking preva-
lence has declined fastest among high risk population
subgroups while for higher merchant compliance [22],
graphic warnings on packages [24], 2010 tax increase
[25] and anti-smoking mass media campaigns [25] over-
all smoking prevalence has also declined, however, for
2010 tax increase the decline in smoking did not sustain
after 3 months [26]. The faster decline of smoking as
seen in high risk population groups is non-existent for
the use of mass media [27] while there is no comparable
data for introduction to plain packaging or graphic
warnings on packages.
Smoking rate in the selected high risk groups
The smoking prevalence in 2014–15 National Health
Survey (NHS) was 14.5% overall and 16.9% for males
and 12.1% for females [28]. There were 21.4% of people
who were most disadvantaged (first quintile) and
smoked daily, compared with 8.0% of people who were
the least disadvantaged (fifth quintile). Rates of smoking
have decreased over the past decade in all quintiles of
disadvantage. However, the daily smoking rate of 21.4%
for the most disadvantaged is still the highest among all
the disadvantaged groups.
The mentally ill represented 17.5% of the Australian
adult population in 2016 [29]. Data from the 2016 Na-
tional Drug Strategy Household Survey also showed that
Australian adults who reported having been diagnosed
or treated for mental illness in the past year had 25.9%
smoking rate which was more than twice as likely than
that of 12.3% for those who were not diagnosed or
treated in the past year [29].
Although smoking prevalence among prisoners (74%)
[30] and homeless (77%) [13] was even higher than
among mentally ill (25.9%) and those having low socio-
economic status (SES) (21.4%), they represented a much
smaller fraction of smoking population as the prisoners
and homeless both represented less than 1% of the total
population in Australia in 2014 [31, 13]. The indigenous
had a 41.85% rate of daily smoking in 2014–15 [32]
which was much lower than the prisoners and homeless,
but they represented a small fraction (around 1.7%) of
smoking population similar but slightly larger than the
prisoners and homeless.
Effectiveness of population-based approach versus high
risk approach for preventing disease
Rose (2001) proposed that preventing disease by trying
to shift the whole population distribution of a risk factor
can be more efficient than focusing interventions solely
on people at high risk [33]. This occurs when a disease
is widespread and many cases of the disease arise in in-
dividuals who are not in a high-risk group, and the num-
ber of cases arising from the population at average risk
is often greater than the number occurring in the popu-
lation at high risk simply because there are so many
more people in the average-risk population. However,
when many cases of disease arise in individuals who are
in a high-risk group such disease is not compliant to the
population disease prevention strategy and hence it is
possible that for a certain disease the high risk approach
can be more efficient. The optimum preventive strategy
therefore depends on the disease to be prevented, the
distribution of its risk factors in the population and the




The primary data source is 2014–15 NHS which is a na-
tionally representative survey in Australia having de-
tailed information on health risk factors, socioeconomic
and demographic characteristics and health services. It is
the most recent in a series of Australia-wide health sur-
veys conducted by the Australian Bureau of Statistics
and was conducted in all states and territories and
across urban, rural and remote areas of Australia (other
than very remote areas) from July 2014 to June 2015.
The other data sources include the 2011 Australian cen-
sus, 2011–13 Australian Health Survey (AHS), 2016 Na-
tional Drug Strategy Household Survey, ABS Prisoners
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Australia 2014 and Australian census-based population
and death counts for 2015–17.
Ethics
The study was not required to be submitted and ap-
proved by the institutional ethics committee of Western
Sydney University where the author is based. The need
for ethics approval was waived by an IRB or was deemed
unnecessary according to national regulations, with the
name of the IRB or a reference to the relevant legislation
being EX2020–13.
Simulation methodology
Using the 2014–15 NHS sample a random reduction in
smoking prevalence to 10 and 0% was simulated for the
whole sample as well as for a specific high risk group
and a combination of the two. First, a random general
reduction, where the simulated reduction was randomly
selected in the whole sample, with selected individuals
becoming non-smokers. This was labelled the ‘popula-
tion approach’. The second approach, labelled the “high
risk approach”, was designed to target a specific high
risk group (i.e. prisoners, homeless, mentally ill, indigen-
ous, low SES), with the prevalence reduction occurring
only in a specific group.
Finally, a combination of the specific approach with
the population approach, labelled the “combined ap-
proach”, was designed to target a specific group as well
as the whole sample. Each smoking prevalence reduction
scenario and combined scenario was simulated inde-
pendently of each other.
Using the 2014–15 NHS linked to ABS’s deaths regis-
try till 2017 the current smoking status of individuals
was assigned while their SES was assigned according to
the 2011 Index of Relative Socioeconomic Disadvantage
(SEIFA) variable available in the same linked dataset.
However, the variables which were either not available
(eg., indigenous status, prisoner status, homelessness sta-
tus, total cholesterol level) or underestimated (eg., men-
tal disorder status) in the linked 2014–15 NHS were
simulated. For example, indigenous status was simulated
by preferentially assigning those who are indigenous to
lower SES quintiles, using the following distribution:
32.3, 29.3, 19.7, 11.3 and 7.4%. This is an approximation
of the distribution found on ABS’s 2011 census [34].
Among indigenous males, 32.2% were current smokers
while among indigenous females 31.15% were current
smokers. Of those males belonging to the lowest SES
quintile, 92.85% were current smokers while for females
belonging to this group, 85.18% were current smokers.
The age-sex distribution of mental disorder status
among the individuals was simulated using the age and
sex distribution of those who are mentally ill according
to the 2016 National Drug Strategy Household Survey
having an overall prevalence of 17.5% [29]. 25.9% of
those mentally ill were assigned to current smoker cat-
egory and the rest 74.1% to non-smoker category. For
mentally ill males 85.74% were current smokers while
for mentally ill females 70.4% were current smokers.
The distribution of prisoners according to age and sex in
Australian Bureau of Statistics (ABS) Prisoners Australia
2014 was used to simulate prisoner status having an
overall prevalence of 0.1856% [31]. 74% of the prisoners
were assigned to current smoker category and the rest
26% to non-smoker category. Homelessness status (HL)
was attributed according to age, sex and indigenous sta-
tus (IS) for 2011 census [34]. All homeless individuals
were allocated to the lowest SES category. For the home-
less males, 9.7% were smokers while for homeless fe-
males, 8.5% were smokers. The age-sex distribution of
the risk factor total cholesterol level was simulated using
its age and sex distribution from the 2011–13 AHS [35]
which has a new collection called the biomedical mea-
sures component where total cholesterol was measured
by blood test. Figure 1 below shows the variables simu-
lated and their data sources.
In our scenario modelling to reduce the overall smok-
ing prevalence randomly to 10%, the smoking status of
some individuals in the sample who were current
smokers was randomly changed to “non-smoker” by
sorting the distribution of current smoking by a random
variable generated from continuous uniform distribu-
tion. On the contrary, the smoking status of non-
smokers was not changed. For a person whose status
changed from smoker to non-smoker, we then obtained
a reduced risk of mortality and smoking prevalence
compared to the data on smoking prevalence we simu-
lated as described above. The random selection process
was replicated 1000 times and the study outputs, such
as, ALEs as presented in this article, are all averages over
the 1000 replications. An identical method was per-
formed to achieve a smoking prevalence of 10% under a
specific high risk or combined scenario (e.g. combined
population, homeless, indigenous, mentally ill, lowest
SES group), by randomly selecting some of the current
smokers belonging to a relevant group or groups to have
their smoking status changed to non-smoking.
External validation of the EURO SCORE to the 2014–15
NHS data
The age, total cholesterol and systolic blood pressure
variables from 2014 to 15 NHS were used to estimate
the absolute risk of all-cause death separately for males
and females aged 15 and above using the EURO SCORE
risk equations. To assess the suitability of the SCORE
statistic as a proxy for all-cause mortality risk in this
study, we used the 2014–15 NHS sample linked pro-
spectively to ABS’s Australian death registry data for 2
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years till 2017. We used Cox proportional hazards regres-
sion separately for males and females for predicting the
risk of all-cause death with the SCORE statistic and age
(continuous) as predictors. As the SCORE statistic was de-
veloped to allocate short-term mortality, we chose a
follow-up of 2 years in our study. Age was included along-
side SCORE as predictors because the EURO SCORE
equation was used in this study on a sample aged 15 and
above while it was originally developed for a European co-
hort aged 45–64. We also fitted Cox regression to ages 65
and over to demonstrate the predictive and discriminatory
abilities of SCORE at older ages. The regression equations’
fit and discriminatory abilities were assessed using the
Hosmer-Lemeshow and Harrell’s C statistics [36, 37]. The
external validation methodology for the EURO SCORE
equation as discussed above is similar to the ones used in
our previous studies [38, 39].
Risk percentiles method
The risk percentiles method was used for estimating the
average life expectancy (ALE) within the simulated Aus-
tralian population or subgroups. An earlier coronary
heart disease (CHD) prevention model was modified to
obtain this method [40]. Details of this method and the
calculations of ALE are provided in Appendix (check
‘Additional file 1.docx’). Briefly, the steps required are:
 Use the EURO SCORE to estimate risk scores for
mortality for every individual in our study cohort.
 Using these risk scores divide the cohort into
mortality risk percentiles.
 Estimate the ratios of risk scores for smokers
relative to non-smokers and use them to proportion-
ately allocate ABS death counts to each sex and age
group specific risk percentiles in the Australian
population from 2015 to 2017.
 Within each sex and age group divide these death
counts by the sex and age group-specific Australian
population to give us the mortality rate for each risk
percentile group.
 Using these mortality rates construct sex-specific life
tables for each risk percentile within each sex group.
 For each sex calculate a baseline ALE per person by
averaging the life expectancy associated with each
risk level over the population.
 Construct 95% confidence interval for ALE using
bootstrapping.
 In order to achieve the desired target of 10%
smoking prevalence change a certain percentage of
current smokers to non-smokers.
 Participants are then re-allocated to risk percentiles.
 Calculate the scenario ALE by averaging the life
expectancy associated with each re-allocated risk
level over the population.
 Construct 95% confidence interval for the scenario
ALE using bootstrapping.
 Calculate the gain in ALE by subtracting the average
life expectancy for the “Base Scenario” from that for
each intervention.
For each sex a total of 23 scenarios were simulated as
shown in Table 1.
We simulated a total of 1000 replications. The soft-
ware SAS version 9.4 was used to perform all simula-
tions and analyses [41].
Results
Sensitivity analysis
Although SCORE was originally derived to predict risk
at ages 45–64, it was applied to ages 15 and over in this
study. So to demonstrate SCORE’s overall ability to pre-
dict all-cause mortality risk to ages 15 and over we fitted
the Cox regression and also fitted a separate regression
Fig. 1 Flow chart of variables simulated and their sources
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to ages 65 and over to demonstrate its predictive ability
at older ages. There were 283 deaths prior to 1 June
2017 among the 18,287 records linked to the outcome.
For both men and women, the EURO SCORE index was
a strongly significant predictor of mortality for ages 15
and over (results not shown). The adjusted Hosmer-
Lemeshow goodness of fit statistic showed no evidence
of lack of fit for both males and females (adj HL (df) =
7.70 (9), p = 0.564 for males; adj HL (df) = 7.41 (9), p =
0.594 for females) and the C statistics had values of
86.8% for men and 90% for women [42] where C values
above 80% are generally regarded as demonstrating ex-
cellent discriminatory power [43]. The SCORE index
was still a strong predictor (p < 0.0001) of mortality for
either males or females when the regression is restricted
to ages 65 and over while the adjusted Hosmer-
Lemeshow goodness of fit statistic showed no evidence
of lack of fit in either equation and the C statistics
showed reasonable discriminatory power with values of
74% for men and 74.5% for women.
Table 1 Description of the simulated scenarios
Scenario Targeted Population Change in smoking behavior
Base scenario Whole population No change in baseline smoking prevalence for
both men and women
10% prevalence in Whole population Whole population Prevalence randomly reduced to 10% for
both men and women
0% prevalence in Whole population Whole population All smokers in targeted group quit
10% prevalence in homeless Homeless Group Prevalence randomly reduced to 10% for
both men and women who are homeless
10% prevalence in both population &
homeless
Whole population & homeless Group Prevalence randomly reduced to 10% for
both men and women in targeted groups
0% prevalence in homeless Homeless Group All smokers in targeted group quit
0% prevalence in both population &
homeless
Whole population & homeless Group Prevalence reduced to 10% for both
men and women in targeted groups
10% prevalence in drug users Drug users Group Prevalence randomly reduced to 10% for
both men and women who are drug users
10% prevalence in both population &
drug users
Whole population & drug users Group Prevalence randomly reduced to 10% for
both men and women in targeted groups
0% prevalence in drug users Drug users Group All smokers in targeted group quit
0% prevalence in both population &
drug users
Whole population & drug users Group All smokers in targeted groups quit
10% prevalence in mentally ill Mentally ill Group Prevalence randomly reduced to 10% for
both men and women who are mentally ill
10% prevalence in both population &
mentally ill
Whole population & mentally ill group Prevalence randomly reduced to 10% for
both men and women in targeted groups
0% prevalence in mentally ill Mentally ill Group All smokers in targeted group quit
0% prevalence in both population &
mentally ill
Whole population & mentally ill group All smokers in targeted groups quit
10% prevalence in low SES Low SES Group Prevalence randomly reduced to 10% for
both men and women who belong to
low SES group
10% prevalence in both population &
low SES group
Whole population & low SES group Prevalence randomly reduced to 10% for
both men and women in targeted groups
0% prevalence in low SES group Low SES Group All smokers in targeted group quit
0% prevalence in both population &
low SES group
Whole population & low SES Group All smokers in targeted groups quit
10% prevalence in Indigenous group Indigenous Group Prevalence randomly reduced to 10% for
both men and women who are Indigenous
10% prevalence in both population &
Indigenous group
Whole population & Indigenous group Prevalence randomly reduced to 10% for
both men and women in targeted groups
0% prevalence in Indigenous group Indigenous Group All smokers in targeted group quit
0% prevalence in both population &
Indigenous group
Whole population & Indigenous group All smokers in targeted groups quit
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Results of scenario analysis
A gain in ALE associated with the reduction of smoking
prevalence was observed using all the three approaches
[44]. This is shown in Tables 2 and 3. The gain in aver-
age life expectancy using the population approach was
approximately 0.31 years for males and 0.18 years for fe-
males when smoking prevalence was reduced to 10%.
These gains were 40 and 27% of the maximal gains in
ALE that could be achieved through complete cessation
for which the gain was 0.78 years for males and 0.67
years for females.
The gains using the high risk approach were very low
in all specific subgroups, except among mentally ill pop-
ulations. For reductions to 10% smoking prevalence, the
gain in average life expectancy when the mentally ill
were targeted was 0.28 years for males and 0.21 years for
females. For complete smoking cessation, the gain in
average life expectancy when the mentally ill were tar-
geted was 0.40 years for males and 0.29 years for females.
For reductions to 10% smoking prevalence, the gain in
average life expectancy when people in the lowest
socioeconomic quintile were targeted was 0.23 years for
males and 0.17 years for females. For complete smoking
cessation, the gain in average life expectancy when
people in the lowest socioeconomic quintile were tar-
geted was 0.36 years for males and 0.28 years for females.
Both the lowest socioeconomic quintile and mentally ill
subgroups have substantial fraction of smokers in the
population as 20 and 17.5% of the population belongs to
these subgroups respectively. On the contrary, the indi-
genous, homeless and prisoner subgroups have much
smaller fraction of smokers in the population as only
1.7, 0.489 and 0.1856% of the population belongs to
these subgroups respectively.
The gains in ALEs for males and females using the
combined approach compared to the high risk approach
were substantially higher. The combined approach pro-
duced also higher gains in ALE compared to the general
prevalence reduction by population approach. The com-
bined approach was most effective in prolonging survival
when the high risk group being targeted was either the
lowest socioeconomic quintile or the mentally ill. For
Table 2 Gain in average life expectancy in the population
under various smoking reduction scenarios for males
Scenarios ALE
(95% CI)
Gain in ALE relative
to Base scenario
Baseline 36.12 (35.81, 36.43) –
10% rate 36.43 (35.89, 36.88) 0.31
0% rate 36.90 (36.33, 37.63) 0.78
10% rate
Homeless
36.17 (35.69, 36.78) 0.05
10% rate pop & homeless 36.48 (35.86, 37.03) 0.36
0% rate homeless 36.18 (35.65, 36.59) 0.06
0% rate pop & homeless 36.95 (36.34, 37.39) 0.83
10% rate prisoner 36.17 (35.19, 36.82) 0.05
10% rate pop & prisoner 36.51 (35.88, 37.01) 0.39
0% rate prisoner 36.38 (35.85, 36.86) 0.26
0% rate pop & prisoner 37.02 (36.41, 37.47) 0.90
10% rate mentally ill 36.40 (36.04, 37.25) 0.28
10% rate pop & mentally ill 36.65 (36.23,37.61) 0.53
0% rate mentally ill 36.52 (36.49, 38.52) 0.40
0% rate pop & mentally ill 37.15 (36.63, 37.89) 1.03
10% rate indigenous 36.20 (35.12,36.85) 0.08
10% rate pop & Indigenous 36.51 (35.92, 37.17) 0.39
0% rate indigenous 36.21 (35.74, 37.78) 0.09
0% rate pop & indigenous 36.99 (36.33, 37.85) 0.87
10% rate low SES 36.35 (35.90, 37.30) 0.23
10% rate pop & low SES 36.60 (36.05, 37.50) 0.48
0% rate low SES 36.44 (36.00, 37.14) 0.32
0% rate pop & low SES 37.10 (36.47, 38.02) 0.98
Table 3 Gain in average life expectancy in the population
under various smoking reduction scenarios for females
Scenarios ALE
(95% CI)
Gain in ALE relative
to Base scenario
Baseline 40.21 (39.87, 40.55) –
10% rate 40.39 (40.00, 40.97) 0.18
0% rate 40.88 (40.25, 41.37) 0.67
10% rate
Homeless
40.27 (39.42, 40.89) 0.06
10% rate pop & homeless 40.52 (39.88, 41.02) 0.31
0% rate homeless 40.31 (39.61, 40.58) 0.10
0% rate pop & homeless 41.03 (40.22, 41.48) 0.82
10% rate prisoner 40.25 (39.70, 40.65) 0.04
10% rate pop & homeless 40.48 (39.97,40.88) 0.27
0% rate prisoner 40.33 (39.83, 40.38) 0.12
0% rate pop & prisoner 40.97 (40.08, 41.58) 0.76
10% rate mentally ill 40.42 (39.92, 40.88) 0.21
10% rate pop & mentally ill 40.58 (39.98, 41.30) 0.36
0% rate mentally ill 40.50 (40.10, 40.97) 0.29
0% rate pop & mentally ill 41.06 (40.63, 41.57) 0.85
10% rate indigenous 40.32 (39.86,40.79) 0.11
10% rate pop & Indigenous 40.50 (40.04, 41.23) 0.29
0% rate indigenous 40.37 (39.88, 40.93) 0.16
0% rate pop & indigenous 41.04 (40.40, 41.86) 0.83
10% rate low SES 40.38 (39.92, 41.08) 0.17
10% rate pop & low SES 40.52 (39.94, 41.13) 0.31
0% rate low SES 40.49 (40.02, 41.51) 0.28
0% rate pop & low SES 41.09 (40.54, 41.83) 0.88
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those in the lowest socioeconomic quintile this gain was
0.48 years for males and 0.31 years for females when
smoking prevalence was reduced to 10%, which were
around 49 and 35% respectively of the maximal gains in
ALE that could be achieved through complete cessation
using combined approach. For those who were mentally
ill this gain was 0.53 years for males and 0.36 years for
females which were around 51 and 42% respectively of
the maximal gains in ALE that could be achieved
through complete cessation using combined approach.
Discussion
In Australia, smoking is the single most important pre-
ventable cause of ill health and death even though the
prevalence of smoking has been declining since the
1950s, and Australia currently has one of the lowest
rates of smoking in the developed world. Prevalence of
smoking has declined more rapidly in high risk groups
particularly among those belonging to socially disadvan-
taged groups. As a result, there is a narrowing down of
gap in smoking prevalence between high risk and low
risk population groups. Smoking prevalence is still
double in high risk population groups which is why one
of the key priority areas of Australia’s 2012–18 National
Tobacco Strategy has been to strengthen efforts to re-
duce smoking in these groups [45]. But, not all tobacco
control measures effectively used in the general popula-
tion may be effective in specific high-risk population
groups. Therefore, in addition to population-based strat-
egies, another way for effectively reducing smoking in
high risk population groups may be to target these
groups to more effectively identify and support those
smoking to quit, also known as the high risk approach.
It is however unknown whether the population-based to-
bacco control intervention is more effective in increasing
life expectancy among Australians compared to a high
risk tobacco control intervention. A previous study ex-
amined gains in life expectancy in Australia due to re-
duction of smoking prevalence to 0 and 10% in the
whole population and below different ages [46], but not
for the key high risk population subgroups for reducing
smoking prevalence, a task which was undertaken in the
present study.
We considered all-cause mortality rather than disease
specific mortality as our outcome for estimating average
life expectancy because the former is an ultimate indica-
tor of health. Using the risk percentiles approach which
assumes that baseline death rates remain stable through-
out lifespan and there is no net migration, analyses were
performed separately for men and women using actual
data from the 2014–15 NHS, simulated data from vari-
ous sources and actual population and death counts for
2015–17. We examined the key high risk population
subgroups such as people belonging to lowest quintiles,
indigenous, homeless, prisoners and mentally ill. A 10%
smoking prevalence by 2020 was proposed as a feasible
target by the National Preventive Taskforce [47] and
there is growing evidence that this is well underway [48].
Thus, the scenarios we analyzed are expected to be po-
tentially achievable.
The results showed that for reduction to a smoking
prevalence of 10% the population approach is more ef-
fective in terms of life expectancy gains than the high
risk approach of targeting the homeless or prisoner or
low SES or indigenous, but is less effective than targeting
mentally ill. The latter which although represents a rea-
sonably large fraction of smoking population doesn’t
have as high smoking prevalence as some other high risk
population groups examined, particularly homeless and
prisoners. For complete smoking cessation, the popula-
tion approach is found more effective than the high risk
approach. The combined approach is however the most
effective for reducing smoking to both 10 and 0% and is
the optimum preventive strategy for reducing smoking
prevalence.
The optimum strategy for preventing smoking-related
diseases, however, depends on the disease to be pre-
vented; the distribution of smoking prevalence in the
population and the likelihood of achieving the desired
reduction in smoking prevalence. The major smoking-
related diseases in Australia such as CVD, lung cancer
and COPD are concentrated in low or moderate risk
population subgroups. For instance, AIHW (2014) re-
ported that combinedly for the Australian states of New
South Wales, Victoria, Queensland, Western Australia
and that of Northern Territory, 98.05% (n = 42,498) of
new cases of lung cancer during 2008–2012 came from
the non-indigenous population which is broadly a low
risk population subgroup compared to the indigenous,
whereas only 1.95% (n = 845) arose from the latter which
is a high risk population subgroup [49]. Similarly, people
with cardiovascular diseases were more likely (78%) to
live in a low risk population subgroup, e.g., those living
in less disadvantaged socioeconomic areas, compared to
those living in a high risk population subgroup, for ex-
ample, those living in highly disadvantaged socioeco-
nomic areas (22%) [50]. As non-indigenous and less
socially disadvantaged people live all across Australia
this may imply that lung cancer and cardiovascular dis-
eases are widespread across Australia although in high
risk groups lung cancer [51] and CVD [52] are more
common in relative terms. Furthermore, despite many
years of targeting high risk groups for smoking reduc-
tion, smoking prevalence in these groups still remain
considerably higher than low or moderate risk groups.
In this study, the effect of smoking cessation and re-
duction of smoking prevalence to 10% when the whole
population is targeted for such reduction was lower than
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that encountered in the previous Mannan et al. (2016)
study [46] using the same methodology. This difference
is mainly due to the decline in smoking prevalence in
2014–2015 compared to 1999–2000 which was the base-
line for the previous study.
In the present analysis the absolute risk of death of in-
dividuals was estimated prospectively on the basis of
baseline cardiovascular risk factors similar to a cohort
study. From the positive side it reduces the time and
cost associated with collecting repeated measures data
for risk factors; on the contrary, the use of life table
method in a cross-sectional setting makes certain as-
sumptions for estimating the long-term effects of
changes in the smoking behavior on improvements in
life expectancy. The key assumption which was made is
that the age-sex specific mortality rate for each risk per-
centile for the baseline and intervention scenarios would
continue for the rest of the life of each member of a risk
percentile. The EURO SCORE did not separate past
smoking from never smoking. The impact of ignoring
this risk stratification on life expectancy gains was not
directly examined. However, since for quitting as high as
before 55 years, there is no excess risk of death from all
major CVD causes compared to never smokers [3], the
effect of not making the above distinction in smoking
categorization, on the life expectancy gains, may not be
too pronounced. In this study we did not recalibrate a
Framingham based all-cause mortality risk equation [53]
to the Australian population, because it was not devel-
oped separately for men and women as was required for
this study.
The more well-known population attributable risk
method [54] is simpler than the risk percentiles method
for estimating improvements in life expectancy. But, the
advantage of using risk percentiles method is that it
already incorporates the life table and so we can esti-
mate life expectancy as a direct output. In contrast, the
population attributable risk method alone is not suffi-
cient to estimate improvements in life expectancy.
The non-J shaped relationship between intensity and
duration of cigarette smoking and chronic diseases im-
plies that the population approach reduces the risk of
everyone in the population [55]. In Australia, the major
smoking-related diseases are spread all across the popu-
lation. However, since the combined approach of redu-
cing smoking is most effective for improving life
expectancy of Australians particularly when the high risk
groups have a high fraction of smokers in the popula-
tion, it is evident that targeting these groups for smoking
reductions can strongly complement the existing
population-based smoking reduction strategies. We be-
lieve that the “high risk” approach is not interfering with
potential “population strategies”. Population strategies
like increasing price and duty for cigarettes, bans on
advertising, public health campaigns, smoke free legisla-
tion, jurisdictional bans and limitations on point of sale
display, mandatory graphic health warnings on pack-
aging will help to further reduce smoking prevalence in
Australia. We believe that although the disparity in
smoking prevalence between high risk and normal or
low risk population subgroups has started to narrow
down, this can be accelerated by specifically targeting
high risk groups for smoking reduction. By applying sys-
tematic policy and population-based tobacco control
programs with proven effectiveness to these high risk
groups, their smoking prevalence can be reduced and
subsequently tobacco-related disparities between the
groups can be narrowed down. Furthermore, tailoring of
population-based tobacco control strategies in these spe-
cific population groups is necessary when it’s
appropriate.
Conclusions
Targeting both the population as well as a high prevalent
smoking subgroup having a large fraction of smokers in
the population for smoking reduction contributes more
to population health gains in Australia than targeting
the population alone for smoking reduction. Therefore,
as both approaches are important, the national preven-
tion policies should make judicious use of both to
maximize health gain.
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